ÂÜÀòÂÒÂ×

Jameson Walsh is an experienced professional in the biopharmaceutical industry, currently serving as the Enterprise Process Lead for Drug Substance Production (API & Biologics) at AstraZeneca since August 2018, focusing on SAP S4/Hana design and migration activities. Previously, Jameson held multiple roles at AstraZeneca, including Sr. Manager of Clinical & Commercial Biologics Production, where leadership of a 45-person team resulted in the production of seven different biologics with annual revenues of approximately $125 million. Prior experience includes positions at Paragon Bioservices, Inc. and GSK, with a strong focus on upstream biologics manufacturing. Jameson's educational background includes a Master of Science in Biotechnology/Bioinformatics from Johns Hopkins University and a Bachelor of Science in Biochemistry and Genetics from Texas A&M University. Currently, Jameson is pursuing an MBA in Logistics, Materials, and Supply Chain Management at the University of South Carolina.